Alogliptin Impurity 12 is a pharmaceutical intermediate used in the manufacturing process of alogliptin, a compound for diabetes research. It is a structurally defined chemical with multiple ring systems and functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Alogliptin Impurity 12?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N-Acetyl alogliptin
pharmaceutical raw material
N-Boc Alogliptin
pharmaceutical raw material
3-(2-Cyanobenzyl) Alogliptin
pharmaceutical intermediate
Alogliptin Impurity 70
pharmaceutical intermediate
3-Amino-4-pyrazolecarboxamide hemisulfate
pharmaceutical intermediate
N-(4-Oxocyclohexyl)acetamide
pharmaceutical intermediate
(s)-2-(1-aminoethyl)-5-bromophenol hydrochloride
pharmaceutical intermediate
Glycine tert butyl ester hydrochloride
pharmaceutical intermediate
N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-1-methyl-2,6-dioxopyrimidin-4-yl]piperidin-3-yl]benzamide
YJMNTJGSDFBRQM-OAQYLSRUSA-N
CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCC[C@H](C3)NC(=O)C4=CC=CC=C4
Sourcing Alogliptin Impurity 12?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.